Marra V, Frigerio A, Di Virgilio M R, Menna S, Burke P
I Centro di Screening Mammografico, Ospedale S. Giovanni Antica Sede, Torino, TO.
Radiol Med. 1999 Nov;98(5):342-6.
To determine how many cancers screen-detected at subsequent rounds were already visible on previous screening mammograms, and to study their radiological features.
The previous screening mammograms of 100 women who had cancers screen-detected at subsequent rounds (group A), and the negative screening mammograms of 200 women (group B) who had a further negative screening test two years later, were mixed for a new reading. The two groups were similar for age and year of examination. These films were blindly reviewed by 5 radiologists. Then, mammograms were reviewed retrospectively, with knowledge of subsequent diagnostic results. Finally the A group findings were classified as: 1) true negative: no radiological signs; 2) minimal sign: a nonspecific abnormality is retrospectively visible at the site of subsequent cancer; 3) false negative: "she should have been recalled"; 4) misdiagnosis at assessment: the woman had been recalled, but the cancer was missed after the assessment procedures.
60% of cases were true negatives, 29% were minimal signs, 9% were false negative and 2% were misdiagnosed at assessment. The most common radiological sign found among false negative cases was an architectural distortion: opacities and calcifications were more frequent among minimal signs. Only 10 of 40 cancers retrospectively visible on previous mammograms had reached stage II at diagnosis. At blinded review, the radiologists found false abnormalities in a considerable number of healthy women (average: 29%).
Our study shows that mammography sensitivity can be improved. Cancer radiological signs may go undetected due to difficult interpretation (opacities, calcifications) or perception (architectural distortions). The use of a low threshold of suspicion (as in a reading test) in real screening might permit to detect more cancers (most of them, however, would not reach advanced stages at subsequent rounds), but might also lead to many unnecessary assessments and, probably, to some benign biopsies in healthy women. In conclusion, an attempt at improving mammography sensitivity by lowering the threshold of suspicion can not be directly recommended due to the considerable negative effects related to a loss in specificity. A reading test similar to the one presented in our study would be a useful training procedure for radiologists who are involved in a screening program.
确定在后续轮次筛查中发现的癌症中有多少在之前的筛查乳腺钼靶片上已可见,并研究其放射学特征。
将100名在后续轮次筛查中发现患有癌症的女性(A组)的先前筛查乳腺钼靶片,与200名两年后再次进行阴性筛查的女性(B组)的阴性筛查乳腺钼靶片混合进行重新阅片。两组在年龄和检查年份方面相似。这两组片子由5名放射科医生进行盲法阅片。然后,在知晓后续诊断结果的情况下对乳腺钼靶片进行回顾性阅片。最后将A组的结果分类为:1)真阴性:无放射学征象;2)微小征象:在后续癌症部位回顾性可见非特异性异常;3)假阴性:“本应召回”;4)评估时误诊:该女性已被召回,但在评估程序后癌症被漏诊。
60%的病例为真阴性,29%为微小征象,9%为假阴性,2%为评估时误诊。在假阴性病例中发现的最常见放射学征象是结构扭曲:在微小征象中,模糊影和钙化更常见。在先前乳腺钼靶片上回顾性可见的40例癌症中,只有10例在诊断时已达到II期。在盲法阅片时,放射科医生在相当数量的健康女性中发现了假异常(平均:29%)。
我们的研究表明乳腺钼靶检查的敏感性可以提高。癌症的放射学征象可能因难以解读(模糊影、钙化)或察觉(结构扭曲)而未被发现。在实际筛查中使用低怀疑阈值(如在阅片测试中)可能会发现更多癌症(然而,其中大多数在后续轮次中不会发展到晚期),但也可能导致许多不必要的评估,并且可能会对健康女性进行一些良性活检。总之,由于与特异性丧失相关的相当大的负面影响,不能直接推荐通过降低怀疑阈值来提高乳腺钼靶检查的敏感性。类似于我们研究中所呈现的阅片测试对于参与筛查项目的放射科医生将是一种有用的培训程序。